Open pelvic lymph node dissection for prostate cancer: a reassessment
References (22)
- et al.
The use of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
J Urol
(1993) - et al.
Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer
J Urol
(1994) - et al.
Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer
J Urol
(1992) - et al.
The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection
J Urol
(1993) - et al.
Staging pelvic lymphadenectomy for carcinoma of the prostate: risk versus benefit
J Urol
(1980) - et al.
Intraoperative and early complications of staging pelvic lymph node dissection in prostatic adenocarcinoma
Urology
(1990) - et al.
Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade
Urology
(1993) - et al.
Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients
J Urol
(1989) - et al.
Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer
Urology
(1994) - et al.
Early hospital discharge after radical retropubic prostatectomy: impact on cost and complication rate
Urology
(1994)
Prognostic significance of lymph nodal metastases in prostate cancer
J Urol
Cited by (77)
The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancer
2015, Urologic Oncology: Seminars and Original InvestigationsAppearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10
2010, Clinical ImagingCitation Excerpt :In the third patient with prostate cancer, the extensiveness of the lymphadenopathy was out of proportion to what was expected based on tumor grade and prostate-specific antigen (PSA) level. Previous studies have shown that nodal metastases in prostate cancer are usually not seen until the Gleason score is over 6 and the blood PSA level is over 10 [9]. This patient had extensive malignant lymphadenopathy in the left external, bilateral obturator, bilateral common iliac, and paraaortic regions, despite a Gleason score of 6 and a PSA of 7.4.
Lymphadenectomy in prostate and bladder cancer: Technique and indications
2010, Progres en Urologie - FMCThe Use of a Surgical Patch in the Prevention of Lymphoceles After Extraperitoneal Pelvic Lymphadenectomy for Prostate Cancer: A Randomized Prospective Pilot Study
2009, Journal of UrologyCitation Excerpt :In the studies that may be found in the literature there is a low lymphocele rate. However, the number of lymph nodes removed during radical prostatectomy may vary greatly and, thus, so does the rate of complications that may be found in a retrospective study but not in a controlled prospective one.3–5,13,14 We believe that you find what you look for.
Regional lymph node staging in prostate cancer: Prognostic and therapeutic implications
2009, Surgical Oncology